Open AccessSuboxone® (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis
Author(s) -
José Martı́nez-Raga,
Francisco González Saiz,
César Pascual,
Miguel Á. Casado,
Francisco J. Sabater Torres
Publication year - 2009
Publication title -
european addiction research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.862
H-Index - 54
eISSN - 1421-9891
pISSN - 1022-6877
DOI - 10.1159/000259614
Subject(s) - buprenorphine , methadone , (+) naloxone , agonist , medicine , opioid , opiate , emergency medicine , anesthesia , receptor
To evaluate the economic impact of buprenorphine/naloxone (B/N) as an agonist opioid treatment for opiate dependence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom